Edible protein substances composed of fungal mycellium

Information

  • Patent Grant
  • 4061781
  • Patent Number
    4,061,781
  • Date Filed
    Thursday, August 5, 1976
    48 years ago
  • Date Issued
    Tuesday, December 6, 1977
    47 years ago
Abstract
An edible protein-containing substance is produced by incubating and proliferating, under aerobic conditions, a nontoxic strain of the genus Fusarium or a variant or mutant thereof, in a culture medium containing essential growth-promoting nutrient substances, of which carbon in the form of assimilable carbohydrate constitutes the limited substrate in proliferation, and separating the proliferated organism comprising the edible protein-containing substance. Novel strains and variants of Fusarium graminearum are disclosed.
Description

The present invention relates to a process for the production of edible protein-containing substances and has particular reference to the production of fungal protein by microbial action.
Our copending United Kingdom Application No. 53312/66, Ser. No. 1210356, relates to a process for the production of an edible protein-containing substance which comprises incubating and proliferating, under aerobic conditions, an organism which is a non-toxic strain of a microfungus of the class Fungi Imperfecti, in a culture medium containing essential growth-promoting nutrient substances, of which carbon in the form of assimilable carbohydrate constitutes the limiting substrate in proliferation, and separating from a assimilable carbohydrate exhausted medium the proliferated organism which constitutes the edible protein-containing substance.
It is also an object of the present invention to provide fungal mycelium which possesses a high net protein utilisation value on rat assays of at least 70 based on the .alpha.-amino nitrogen. However, as indicated in one of the examples, it is possible to have a net protein utilization value of at least 65.
According to the present invention there is provided a process for the production of an edible protein-containing substance which comprises incubating and proliferating, under aerobic conditions, a non-toxic strain of the genus Fusarium or a variant or mutant thereof, in a culture medium containing essential growth-promoting nutrient substances, of which carbon in the form of assimilable carbohydrate constitutes the limiting substrate in proliferation, and separating the proliferated organism comprising the edible protein-containing substance.
The separated proliferated organism comprising the edible protein-containing substance may be incorporated into a foodstuff for human or animal consumption.
The substrate employed in the incubation stage may be of vegetable origin, for example starch, starch containing materials or products of their hydrolysis, sucrose, sucrose containing materials or hydrolysed sucrose i.e. invert sugar or mixtures thereof. Thus the substrate may comprise hydrolysed potato, molasses, glucose, hydrolysed bean starch or cassava. Alternatively substrate of animal origin comprising whey may be employed.
The non-toxic strain of Fusarium may be a strain of Fusarium graminearum.
The preferred non-toxic strain is our strain of Fusarium graminearum Schwabe, IO deposited with the Commonwealth Mycological Institute and assigned the number I.M.I. 145425 and variants and mutants thereof.
The following novel variants may also be employed:
I-7 deposited with the Commonwealth Mycological Institute and assigned the number I.M.I. 154209.
I-8 deposited with the Commonwealth Mycological Institute and assigned the number I.M.I. 154211.
I-9 deposited with the Commonwealth Mycological Institute and assigned the number I.M.I. 154212.
I-15 deposited with the Commonwealth Mycological Institute and assigned the number I.M.I. 154213.
I-16 deposited with the Commonwealth Mycological Institute and assigned the number I.M.I. 154210.
Our new strain of Fusarium graminearum Schwabe, I.M.I. 145425, is non-pathogenic to wheat. It has the following morphological characteristics:
______________________________________ Czapek-Dox (Modified)Media Potato Sucrose Agar Agar (Oxoid)______________________________________250 grams of potatoeswashed and diced, placedin pressure cooker 15 lbs.square inch for 15 minutes.The decoction is thensqueezed through twolayers of muslin. 2% ofGlucose & 2% of Agarare added to the turbidfiltrate and the mediumautoclaved and dispersed.______________________________________
Growth conditions: 25.degree. C. several weeks
Rate of growth: 4.0 cm. in 3 days; 3.0 cm. in 3 days
Character of growth: Floccose, spreading colonies with white aerial mycelium. Substratum on PSA greyish rose with patches of crimson to yellow. Tendency to be somewhat paler on CDA. Occasionally deep red pigment produced, particularly on ageing. After one to two weeks the aerial mycelium tends to become brown and collapse. The colony then becomes rather slimy as sporodochia are formed the colour being pink to brown on PSA and salmon pink on CDA. No exudate is formed and pigment formation tends to follow the mycelium colour.
Conidia: Microconidia not produced by this organism. Macroconidia produced from single lateral phialides or multibranched conidiophores with short phialides. In older cultures the conidiophores aggregate to form sporodochia, particularly on CDA. The conidia vary from falcate to curved fusoid dorsi-ventral, septation varying from 3 to 5, commonly 5 in younger cultures. Spore size varies from 25 - 50.mu. .times. 2.5.mu. - 4.0.mu..
The foot cell is often pedicellate, particularly in the longer 5 septate spores. Swollen cells occur in the mycelium and occasionally chlamydospores occur intercalary, singly or in chains.
Following is a description by way of example of the preparation of variants (or isolates) of Fusarium graminearum Schwabe I.M.I. 145425 and their morphological characteristics.
Isolates obtained from continuous culture
Fusarium graminearum Schwabe I.M.I. 154209 to 154213 were selected from malt extract agar plates inoculated with broth from a fermenter growing Fusarium graminearum Schwabe 145245 on a glucose/salts medium at 30.degree. C. under continuous culture conditions with carbon limitation at a dilution rate of 0.1 - 0.15 hr.sup.-1. The fermenter was sampled at approximately 100 hour intervals to assess the population of variants and the isolates I.M.I. 154209 to 154213 were taken from the plates prepared from the 1100 hour sample. These isolates are representative of the major types of morphological variant produced during the fermentation. Under these conditions outlined in this example the variants begin to appear on plates from 800 hours onwards. They are continually produced from this time onward and the population slowly changes as regards the percentage of each type. The fermenter conditions are as follows:
______________________________________Culture medium %______________________________________Solution 1 Glucose 3.0 Ammonium sulphate 0.25 Potassium di-hydrogen 0.30 phosphate Magnesium sulphate 0.025 Antifoam, polypropylene 0.01 glycol 2000; sterilised at pH 3.0 for 30 mins. at 15 p.s.i.g.Solution 2 MnSO.sub.4 4H.sub.2 O 0.0005 FeSO.sub.4 7H.sub.2 O 0.0005 ZnSO.sub.4 7H.sub.2 O 0.0005 CoCl.sub.2 6H.sub.2 O 0.0001 CuSo.sub.4 5H.sub.2 O 0.0001 Na.sub.2 MoO.sub.4 2H.sub.2 O 0.0001 Sterilised 15 mins. at 15 p.s.i.g.Solution 3 Biotin 0, 10 or 20 .mu.g/l Choline 0, 1 or 2 mg/l Methionine 0 or 600 mg/l Sterilised separately by filtration______________________________________
All solutions were added, as necessary, aseptically to the medium reservoir then fed to the 8.5 litre chemostat with the following growth conditions:
Temperature 30.degree. C., aeration 1vvm (i.e., 1 volume air/volume culture medium/minute); agitation 800 r.p.m., single 6-bladed disc turbine, 0.5D, in fully baffled fermenter. The fermenter pH was maintained at 5.0 by the automatic addition of sterile ammonia. Solution 3 was changed in composition at various times to determine .mu.max with the various additions such as biotin alone or biotin plus choline. Growth rate 0.1 to 0.15 hr.sup.-1.
The five isolates have the following morphological characteristics.
______________________________________ Czapek DoxMedia Potato Sucrose Agar Agar (Oxoid)______________________________________250 grams of potatoeswashed and diced, placedin pressure cooker 15 lbs.square inch for 15 minutes.The decoction is thensqueezed through two layersof muslin. 2% of Glucose& 2% of Agar are added tothe turbid filtrate andthe medium autoclaved anddispersed.______________________________________
Growth conditions: 25.degree. C.
Character of growth
Isolate I-7
Colony morphology similar to parent A3/5 except colony diameter is smaller, 1.5cm in three days at 30.degree. C. on C.D.A. The floccose aerial mycelium varies in degree from colony to colony but is less than I-8. Older cultures have a brown discoloration to the mycelium. Reverse, yellow-brown to greyish-rose sectors with some pigment diffusing.
Isolate I-8
Very intense white floccose aerial mycelium. Colony diameter again less than parent A3/5, 2.0 cm in three days at 30.degree. C. on C.D.A. Reverse salmon pink to greyish-rose segments.
Isolate I-9
Macroscopic appearance close to I-8 but reverse lighter, salmon to hyaline in colour.
Isolate I-15
Small restricted dome shape colonies. Mycelium short, tangled and with tendency to be convoluted. Many sporodochia-like structures formed giving pink appearance at point of inoculation of streak. Pink coloration at periphery. Colony diameter only 0.4cm at 3 days at 30.degree. C. on C.D.A.
Isolate I-16
Isolate I-15 is very unstable and continually gives rise to I-16. This isolate has an appearance similar to I-7 although colonies tend to be slightly greater in diameter, 2.4cm. in 3 days and more even in appearance. I-16 is more stable than I-15.
CONIDIA
Isolate I-7
Abundant macroconidia produced in similar fashion to parent A3/5. Sporadochia formed in older cultures. Individual macroconidia similar to parent A3/5 in shape and size, 25-50.mu. .times. 3.0-5.0.mu.. In older cultures many sporodochia are formed. Chlamydospores are also abundant in the mycelium of this isolate, intercalary and terminal. They are globose smooth 10-12.mu.. Occasionally a single cell of a macroconidium forms a chlamydospore.
Isolate I-8
Fewer macroconidia than I-7 and those present mainly smaller and simpler, 1 to 3 septate, 25-35.mu. in length. Few sporodochia formed. Chlamydospores again abundant, intercalary, terminal, single and in chains.
Isolate I-9
Very similar to I-8 except more macroconidia, almost equivalent to I-7 in number.
Isolate I-15
Very few macroconidia, the sporodochia-type structures are in fact made up of packets of chlamydospores. There are also many chlamydospores present in the mycelium. The macroconidia are smaller than the parent, 30-35.mu. .times. 4.mu. with only 2 septa.
Isolate I-16
Very similar to I-7 with abundant macroconidia and chlamydospores. The macroconidia are typical, 30-45.mu. .times. 4.mu..
The temperature of incubation in the process of the invention is in general between 25.degree. and 34.degree. C., preferably around 30.degree. C.
Inoculation resulting in commencement of the process is best carried out by a pregerminated seed stage comprising for example from 2% to 10% of inoculum, usually in the range 5% to 10%.
The pH of the substrate medium during incubation is preferably kept within a suitable range supporting maximum growth, for example, between 3.5 to 7.
The period of growth in batch culture under the above mentioned conditions is usually found to range from 20 to 48 hours. In both batch and continuous processes aeration and agitation should be carried out to provide a sufficient level of dissolved oxygen to overcome deficiency which can be a limiting growth factor.
As will be well understood by those skilled in the art sufficient quantities of essential growth nutrients such as nitrogen, sulphur, phosphorus and other trace elements are maintained in the substrate medium so that growth of the substance is limited only by the carbohydrate available to the fungus.
In addition to the nutrients stated above the presence of one or more vitamins such for example as biotin may be desirable to maintain maximum growth rate.
It is also desirable to add a non-toxic anti-foaming agent to the substrate medium to control foaming during the fermentation.
The substance produced according to the present invention may be isolated in any suitable manner known in the art. Thus the resulting mycelium may be recovered by separation, washing, filtration and drying. In this connection, however, it has been found that if the moisture content of the substance is reduced below a critical level of about 50% (w/w) by filtration under pressure the subsequent drying methods employed are not subjected to such stringent temperature limitations which is an important factor in the economic processing of these materials. The method of drying must not cause damage to the nutritional value of the mycelium and may be drying in a current of air at 75.degree. C. or freeze drying.
The fungal mycelium produced by the process of the present invention shows very good water binding capacity and may be useful as a thickening and gelling agent. Not being an isolate, it retains its vitamins as well as other nutritionally available materials such as lipids and some carbohydrates. Fungal mycelium has satisfactory baking characteristics which are of value in protein enriched breads, breakfast foods and food snacks. The fungal mycelium, because of its filamentous structure, can be baked, fried or puffed and presented to many communities as a food comparable in appearance and acceptability with conventional foods which they are accustomed to eating.
Following is a description by way of example of methods of carrying the invention into effect. Examples 1-4 are of batch culture.





EXAMPLE 1
10 Litres of the following culture medium were prepared and sterilised as described in a stirred fermenter vessel.
______________________________________Cane molasses to provide 6% w/v sugarAmmonium sulphate 1.2%NaH.sub.2 PO.sub.4 0.25%Sterilised 30 minutes 15 psigCaCO.sub.3 0.5% w/vSterilised 3 hours 15 psig______________________________________
The medium components were added aseptically and attemperated to 30.degree. C. An inoculum equivalent to 5-10% by volume of the culture medium and grown either on a glucose/corn steep liquor medium or other suitable materials in shake flasks was inoculated with a spore suspension of the organism comprising our strain of Fusarium graminearum Schwabe I.M.I. 145425, and grown for 18-24 hours at 30.degree. C. on a rotary shaker, and added aseptically to the fermenter.
The fermenter incubated at 30.degree. C. was then stirred at 800 rpm with a 6-bladed disc turbine (0.5D) in a full baffled vessel and 1 VVM of sterile air passed through. After 35 hours, the grown mycelium was removed from the fermenter, centrifuged, washed with water and dried in a warm air band drier, air temperature 75.degree. C.
The dried product had the following composition:
______________________________________Total Nitrogen 8.0%Ash 5.3%Lipid 2.7%NPUop. 52 based on Total Nitrogen______________________________________
where NPUop. is Net Protein Utilization (operative).
EXAMPLE 2
10 Litres of the following culture medium were prepared and sterilised as described, in a 14 litre New Brunswick, Microferm, fermenter.
______________________________________ Final %______________________________________Solution 1 Glucose pH 3.0 3.0Solution 2 Ammonium sulphate 0.7Solution 3 Potassium di-hydrogen pH 5.0 1.0 phosphateSolution 4 FeSO.sub.4 7H.sub.2 O pH 2.5 0.001 MnSO.sub.4 4H.sub.2 O 0.0005 CuSO.sub.4 5H.sub.2 O 0.0001 MgSO.sub.4 7H.sub.2 O 0.025Solution 5 Na.sub.2 MoO.sub.4 2H.sub.2 O 0.0001 CoCl.sub.2 6H.sub.2 O 0.0001 CaCI.sub.2 2 H.sub.2 O 0.0015Solution 6 NaOH 0.1______________________________________
All the above solutions were sterilised by heat for 15 minutes at 15 psig. Solution 7 Vitamins and/or amino acids as described below sterilised by filtration.
The solutions were added aseptically to the vessel.
An inoculum was grown and added as in Example 1 except that the final concentration in the fermenter was adjusted so as to provide 0.5 gm/1 dry wt. of mycelium.
The conditions of growth were temperature 30.degree. C; aeration 1VVM, stirrer speed was adjusted to maintain a level of dissolved oxygen above 25% of the saturation value in the culture medium, measured by a New Brunswick Inc. DO probe. Sterile anti-foam, polypropylene glycol 2000, was added as required to suppress foam and pH was maintained between 6.0 - 6.3 by the addition of sterile potassium hydroxide solution.
______________________________________ Growth rates (hr..sup.-1)______________________________________(i) Omitting solution 7 (Minimal very slow medium)(ii) Solution 7 such that the final concentration of Biotin in the culture medium was 50 .mu.g/l 0.2(iii) Solution 7 such that the final concentration of Biotin in the culture medium was 50 .mu.g/l; 0.25 Choline chloride 30 mg/l and Methionine 300 mg/l______________________________________
EXAMPLE 3
Medium and conditions were as in Example 2, but the glucose was replaced with maltose.
______________________________________(i) Solution 7 as Example 2 (ii) 0.18(ii) Solution 7 as Example 2 (iii) 0.21______________________________________
EXAMPLE 4
100 Litres of the following culture medium were prepared and sterilised as described in a 130 l. stainless steel fermenter.
______________________________________ % final concentration______________________________________Glucose 4.0Corn steep liquor (50% Total 0.8 Solids)Ammonium sulphate 0.2Potassium di-hydrogen phosphate 0.2Mg SO.sub.4 7H.sub.2 O 0.025Zn SO.sub.4 7H.sub.2 O 0.0005Fe SO.sub.4 7H.sub.2 O 0.0005Mn So.sub.4 4H.sub.2 O 0.0001______________________________________
The medium was sterilised at pH 3.0 at 15 psig for 30 minutes and on cooling to 30.degree. C. adjusted to pH 5.0 by the sterile addition of ammonia.
Biotin sterilised by filtration to give 40 .mu.g/l final concentration, was added aseptically.
The vessel was inoculated with 10 litres of culture grown in a sparged vessel, for 18 hours, at 30.degree. C., on a medium containing: Glucose 2%; tryptone (oxoid) 0.4%; yeast extract (oxoid) 0.1%; ammonium sulphate 0.15%; potassium di-hydrogen phosphate 1%; sodium hydroxide 0.1%; magnesium sulphate 0.025%; ferrous sulphate 0.001%; zinc sulphate 0.001%; manganese sulphate 0.0005%; copper sulphate 0.001%; anti-foam, polypropylene glycol 2000 0.05% and sterilised for 45 minutes at 15 psig, inoculated with a spore suspension of our organism Fusarium graminearum Schwabe I.M.I. 145425.
The conditions for growth were temperature 30.degree. C., aeration adjusted to provide dissolved oxygen concentrations above 10% of the saturation value for the culture broth. Sterile anti-foam, polypropylene glycol 2000, was added to suppress foaming, and the pH was maintained at 5.0 by means of sterile ammonia additions. Samples of the mycelium taken over the period of growth contained, on a dry weight basis: Total Nitrogen 8.0 - 8.6%; .alpha.-Amino nitrogen 6.4 - 6.6%. The initial growth rate in this complex medium derived from both the batched culture medium and inoculum was approximately 0.3 hr..sup.-1.
The following Examples 5 and 6 are of continuous culture.
EXAMPLE 5
Culture medium of the following composition was prepared:
______________________________________ Final %______________________________________Solution 1Glucose 3.0Ammonium sulphate 0.25Potassium di-hydrogen phosphate 0.3Magnesium sulphate 0.025Anti-foam, polypropylene 0.01 glycol 2000Sterilised at pH 3.0 for 30 minutes at 15 psigSolution 2MnSO.sub.4 4H.sub.2 O 0.0005FeSO.sub.4 7H.sub.2 O 0.0005ZnSO.sub.4 7H.sub.2 O 0.0005CoCl.sub.2 6H.sub.2 O 0.0001CuSo.sub.4 5H.sub.2 O 0.0001Na.sub.2 MoO.sub.4 2H.sub.2 O 0.0001Sterilised 15 minutes at 15 psig______________________________________
SOLUTION 3
Vitamins and/or amino acid as described below sterilised by filtration.
All solutions were added as necessary, aseptically. In 8.5 litre chemostat the conditions of growth were as follows:
Temperature 30.degree. C; aeration 1VVM; agitation 800 rpm single 6-bladed disc turbine 0.5 D in fully baffled vessel. Organism, our strain of Fusarium graminearum Schwabe I.M.I. 145425. The pH maintained at 5.0 by automatic addition of sterile ammonia.
__________________________________________________________________________ NPU NPU .mu. Max. Yield Mycelium based based hr..sup.-1 factor TN% AN% on TN on AN__________________________________________________________________________(i) Solution 3 such 0.17-0.19 0.5 7.2 to 7.9 6.3 to 6.8 54 65 that the final concentrate of Biotin in the culture medium was 20 .mu.g/l(ii) Solution 3 such that the final 0.20-0.21 0.5 7.7 to 8.6 6.1 to 6.5 59 78 that the final concentration of Biotin in the culture medium was 20 .mu.g/l and of methionine was 600 mg/l__________________________________________________________________________
EXAMPLE 6
Culture medium of the following composition was prepared:
______________________________________ %______________________________________Bean starch (.alpha.-amylase treated) 3.0 carbohydrateCorn steep liquor 1.33Ammonium sulphate 0.25Potassium di-hydrogen phosphate 0.15Magnesium sulphate 0.025Antifoam polypropylene glycol 0.025 2000 (v/w)Sterilised pH 4.0 for 30 minutes at 15 p.s.i.g.______________________________________
The medium was fed to the 8.5 litre chemostat under the same conditions as in Example 5 except that the pH was varied between 3.5 and 6.0 and growth rate throughout 0.1 hr.sup.-1. The following result was obtained:
______________________________________ NPU NPU based based TN% AN% on TN on AN______________________________________Product grown at pH 4.0 7.8 6.6 54 67Product grown at pH 5.0 8.6 7.1 57 71Product grown at pH 6.0 7.7 5.9 61 80______________________________________
EXAMPLE 6b
The culture medium and conditions were as in Example 6 except that the pH was held at 5.0 throughout the run and the temperature was varied between 26 and 34.degree. C. The optimum temperature was found to be 30-32.degree. C.
Examples 7 to 12 describe the fermentation of five variants or isolates of Fusarium graminearum Schwabe I.M.I. 145425.
EXAMPLE 7
Duplicate shake flasks of 1-litre capacity were prepared containing 200 mls. of the following medium:
______________________________________ Final con- centration %______________________________________Solution 1 Glucose (sterilised separately pH 3.0 10 p.s.i./10 min.) 3.0Solution 2 Ammonium sulphate 0.565 Potassium Dihydrogen 1.0 phosphate MgSO.sub.4 :7H.sub.2 O 0.025 FeSO.sub.4 :(NH.sub.4).sub.2 SO.sub.4 :6H.sub.2 O 0.0005 MnSO.sub.4 :4H.sub.2 O 0.0005 CuSO.sub.4 :5H.sub.2 O 0.0001 CoCl.sub.2 :6H.sub.2 O 0.0001 CaCI.sub.2 :2H.sub.2 O 0.0015 Na.sub.2 MoO.sub.4 2H.sub.2 O 0.00001 NaOH 0.2 Salts sterilised at 15 p.s.i.g./15 min. Final pH 6.0Solution 3 Vitamins as described below were sterilised by filtration______________________________________
The solutions were added aseptically to give a final volume of 200 ml. then the flasks were inoculated with washed spores of our strain of Fusarium graminearum I-7 I.M.I. 154209 to give a concentration of 8 .times. 10.sup.3 /ml.
The conditions of growth were temperature 30.degree. C., 140 r.p.m. on orbital shaker with 2 inch throw.
At hourly intervals the growth was measured by measuring the Optical Density of a sample at 600 m.mu.. From the results obtained the following growth rates were established.
______________________________________ Growth rate h.sup.31 1______________________________________(i) Solution 3 omitted (minimal very slow medium)(ii) Solution 3 such that the final concentration of Biotin in the culture medium was 50.mu.g/l 0.22(iii) Solution 3 such that the final concentration of Biotin in the culture medium was 50.mu.g/l and Choline chloride 50 mg/l. 0.27______________________________________
EXAMPLE 8
The procedure of Example 7 was repeated but the strain I-7 was replaced by our strain of Fusarium graminearum Schwabe I-8. The following growth rates were established:
______________________________________ Growth rate h.sup.31 1______________________________________(i) As 7(i) very slow(ii) As 7(ii) 0.22(iii) As 7(iii) 0.27______________________________________
EXAMPLE 9
The procedure of Example 7 was repeated but the strain I-7 was replaced by our strain of Fusarium graminearum Schwabe I-9. The following growth rates were established:
______________________________________ Growth rate h.sup.-1______________________________________(i) As 7(i) very slow(ii) As 7(ii) 0.21(iii) As 7(iii) 0.27______________________________________
EXAMPLE 10
The procedure of Example 7 was repeated but the strain I-7 was replaced by our strain of Fusarium graminearum Schwabe I-15. The following growth rates were established:
______________________________________ Growth rate h.sup.-1______________________________________(i) As 7(i) very slow(ii) As 7(ii) 0.21(iii) As 7(iii) 0.27______________________________________
EXAMPLE 11
The procedure of Example 7 was repeated but the strain I-7 was replaced by our strain of Fusarium graminearum Schwabe I-16. The following growth rates were established:
______________________________________ Growth rate h.sup.-1______________________________________(i) As 7(i) very slow(ii) As 7(ii) 0.21(iii) As 7(iii) 0.27______________________________________
EXAMPLE 12
The procedure of Example 7 was repeated but the strain I-7 was replaced by the parent strain Fusarium graminearum Schwabe I.M.I. 145425. The following growth rates were established:
______________________________________ Growth rate h.sup.-1______________________________________(i) As 7(i) very slow(ii) As 7(ii) 0.22(iii) As 7(iii) 0.27______________________________________
Examples 13 and 14 describe fermentation using strains of Fusaria other than Fusarium graminearum.
EXAMPLE 13
A spore suspension of Fusarium solani strain A7-16 (I.M.I. 154217) was inoculated into a seed fermenter of 80 litre volume containing a glucose, corn steep liquor medium. After growing up the seed fermenter to 10 to 20 gms. per litre, it was split in two, 40 litres to each 400 litre vessel. The seed was inoculated into a medium of the following composition:
______________________________________ %______________________________________Starch 6.0KH.sub.2 PO.sub.4 0.20(NH.sub.4).sub.2 SO.sub.4 0.25Corn Steep Liquor 0.50 (50% Total Solids)______________________________________
pH was 5.5 maintained by addition of sterile ammonia; Temperature 30.degree. C. Pressure 30 p.s.i.g. Air rate 1.0 v.v.m. The revolutions of the stirrer were increased steadily from 92 to 184 r.p.m. to maintain dissolved oxygen in the vessel. The agitator consisted of two turbines 0.4D. When the carbohydrate had been utilised the grown mycelium was removed from the fermenter, filtered, washed with water, centrifuged, and dried in a warm air band drier at 75.degree. C. The dried product had the following composition:
______________________________________Total nitrogen 9.1%Ash 8.3%______________________________________
When fed to rats this material gave an NPUop of 41 based on Total Nitrogen.
EXAMPLE 14
Fusarium oxysporum strain A9-23 (I.M.I. 154214) was grown exactly as in the previous example except the starch was replaced by cane molasses at a concentration that produced 6.0% sugars.
The dried product had the following composition:
______________________________________Total nitrogen 9.9%Ash 10.8%NPUop 47.0 based on Total Nitrogen______________________________________
Methods of analysis for Total Nitrogen (TN) Automatic Kjeldahl digestor (Technicon). A. Ferrari, Ann. N.Y. Sci. 87, 792 (1960).
Amino nitrogen (AN) TNBS (modified). M.A. Pinnegar, Technicon Symposium 1965, p. 80.
These novel strains have also been deposited at the American Type Culture Collection, Rockville, Maryland, and assigned the respective A.T.C.C. numbers:
______________________________________Code No. A.T.C.C. No.______________________________________I 0 20334I 7 20329I 8 20330I 9 20331I 15 20332I 16 20333A9-23 20328A7-16 20327______________________________________
Claims
  • 1. An article of manufacture comprising a nonviable edible non-toxic fungal mycelium of a non-toxic strain of Fusarium possessing a high net protein utilization value of the order of 65 or above based on .alpha.-amino nitrogen.
  • 2. A separated proliferated nonviable edible material comprising an edible non-toxic fungal mycelium of a non-toxic strain of Fusarium possessing a high net protein utilization value of the order of 65 or above based on .alpha.-amino nitrogen.
  • 3. An article of manufacture comprising a nonviable edible mycelium of a non-toxic strain of Fusarium, having a filamentous structure, possessing good water-binding capacity and having a high net protein utilization value of the order of 65 or above based on .alpha.-amino nitrogen.
  • 4. An article of manufacture comprising a dry nonviable edible mycelium of a non-toxic strain of Fusarium, having a filamentous structure, possessing good water-binding capacity and having a high net protein utilization value of the order of 65 or above based on .alpha.-amino nitrogen.
  • 5. A fermentation product comprising a nonviable edible non-toxic fungal mycelium of a non-toxic strain of Fusarium possessing a high net protein utilization value of the order of 70 or above based on .alpha.-amino nitrogen.
  • 6. A fermentation product comprising a nonviable edible non-toxic fungal mycelium of a non-toxic strain of Fusarium selected from the group consisting of Fusarium graminearum, Fusarium solani and Fusarium oxysporum and variants and mutants thereof possessing a high net protein utilization value of the order of 65 or above based on .alpha.-amino nitrogen.
  • 7. A fermentation product comprising a nonviable edible non-toxic fungal mycelium of a non-toxic strain of Fusarium graminearum Schwabe deposited with the Commonwealth Mycological Institute and assigned the number I.M.I. 145425.
  • 8. A fermentation product comprising a nonviable edible non-toxic fungal mycelium of a non-toxic strain of Fusarium graminearum Schwabe deposited with the Commonwealth Mycological Institute and assigned the number I.M.I. 154209.
  • 9. A fermentation product comprising a nonviable edible non-toxic fungal mycelium of a non-toxic strain of Fusarium graminearum Schwabe deposited with the Commonwealth Mycological Institute and assigned the number I.M.I. 154211.
  • 10. A fermentation product comprising a nonviable edible non-toxic fungal mycelium of a non-toxic strain of Fusarium graminearum Schwabe deposited with the Commonwealth Mycological Institute and assigned the number I.M.I. 154212.
  • 11. A fermentation product comprising a nonviable edible non-toxic fungal mycelium of a non-toxic strain of Fusarium graminearum Schwabe deposited with the Commonwealth Mycological Institute and assigned the number I.M.I. 154213.
  • 12. A fermentation product comprising a nonviable edible non-toxic fungal mycelium of a non-toxic strain of Fusarium graminearum Schwabe deposited with the Commonwealth Mycological Institute and assigned the number I.M.I. 154210.
  • 13. A fermentation product comprising a nonviable edible non-toxic fungal mycelium of a non-toxic strain of Fusarium solani deposited with the Commonwealth Mycological Institute and assigned the number I.M.I. 154217.
  • 14. A fermentation product comprising a nonviable edible non-toxic fungal mycelium of a non-toxic strain of Fusarium oxysporum deposited with the Commonwealth Mycological Institute and assigned the number I.M.I. 154214.
  • 15. A fermentation product comprising a nonviable edible non-toxic fungal mycelium of a non-toxic strain of Fusarium possessing a high net protein utilization value of the order of 65 or above based on .alpha.-amino nitrogen.
  • 16. A fermentation product according to claim 15, wherein said product is dry.
  • 17. A fermentation product according to claim 15, wherein said non-toxic strain of Fusarium is a non-toxic strain of Fusarium graminearum Schwabe.
Priority Claims (2)
Number Date Country Kind
23452/70 May 1970 UK
30584/70 Jun 1970 UK
Parent Case Info

This is a continuation of application Ser. No. 414,102 filed Nov. 8, 1973, now abandoned, which in turn is a continuation of application Ser. No. 140,303, filed May 4, 1971, now abandoned.

US Referenced Citations (3)
Number Name Date Kind
2450055 Nord Sep 1948
3151038 Gray Sep 1964
3546071 Douros et al. Dec 1970
Foreign Referenced Citations (1)
Number Date Country
1,085,994 Oct 1967 UK
Non-Patent Literature Citations (2)
Entry
Imholte et al., Journal of Pharmaceutical Sciences, vol. 57, No. 1, pp. 97-100, (1968).
Vinson et al., Science, vol. 101, No. 2624, pp. 388-389, (1945).
Continuations (2)
Number Date Country
Parent 414102 Nov 1973
Parent 140303 May 1971